Alzheimer´s drug Leqembi has full FDA approval
WASHINGTON - US officials granted full approval to a closely watched Alzheimer´s drug, clearing the way for Medicare and other ...
Read moreWASHINGTON - US officials granted full approval to a closely watched Alzheimer´s drug, clearing the way for Medicare and other ...
Read moreCHICAGO - An experimental Alzheimer's drug developed by Eli Lilly and Co slowed cognitive decline by 35 per cent in ...
Read moreWASHINGTON — Medicare’s “Part B” outpatient premium will jump by $21.60 a month in 2022, one of the largest increases ...
Read moreWould you like to receive notifications on our latest news ?
© 2021 All Rights Reserved for Egyptian Gazette - Admined by Digital Transformation Management.
© 2021 All Rights Reserved for Egyptian Gazette - Admined by Digital Transformation Management.